Artiria Medical is a Switzerland-based startup founded in 2019, with a clear mission encapsulated in its slogan: "Enabling a new standard of care to fight stroke and save lives." The company specializes in the empowerment of catheters and guidewires, leveraging cutting-edge technologies to enable seamless navigation and stroke treatment by facilitating micromotion deep in the brain arteries. This innovative approach positions Artiria Medical at the forefront of the Biotechnology and Health Care industries, with a focus on delivering impactful solutions to combat stroke. In its journey to revolutionize stroke treatment, Artiria Medical recently achieved a significant milestone with a $6.00M Series A investment on 28 February 2024, demonstrating strong investor confidence in the company's potential. This substantial investment was secured from a diverse group of backers, including Verve Ventures, Nest Collective Foundation, Wyss Center, Zürcher Kantonal Bank, and 4FO Ventures. This financial backing not only provides the necessary resources for Artiria Medical to further its research and development efforts but also serves as validation of its vision and capabilities. Artiria Medical comprises a passionate and dedicated team committed to redefining the standard of care for stroke surgeons, ultimately benefiting their patients. With its remarkable technological advancements and strong financial support, the company is well-positioned to make a notable impact in the critical field of stroke treatment.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series A | $6.00M | 5 | Zürcher Kantonal Bank, Wyss Center +1 | 28 Feb 2024 |
Debt Financing | Fr.500.00K | 1 | Foundation for Technological Innovation (FIT) | 02 Feb 2024 |
Convertible Note | Fr.1.10M | - | 13 Apr 2022 | |
Grant | Fr.2.69M | 1 | 29 Mar 2022 | |
Series A | Fr.3.00M | 5 | Zürcher Kantonal Bank, 4FO Ventures | 15 Jul 2020 |
No recent news or press coverage available for Artiria Medical .